Article
The effect of protein mutations on drug binding suggests ensuing personalised drug selection.
Scientific reports - 29 Jun 2021
Wan Shunzhou, Kumar Deepak, Ilyin Valentin, Al Homsi Ussama, Sher Gulab, Knuth Alexander, Coveney Peter V
Abstract excerpt
The advent of personalised medicine promises a deeper understanding of mechanisms and therefore therapies. However, the connection between genomic sequences and clinical treatments is often unclear. We studied 50 breast cancer patients belonging to a population-cohort in the state of Qatar. From Sanger sequencing, we identified several new deleterious mutations in the estrogen receptor 1 gene (ESR1). The effect...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
